| pubmed-article:18853322 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C0220633 | lld:lifeskim |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C0893445 | lld:lifeskim |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:18853322 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:18853322 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:18853322 | pubmed:dateCreated | 2008-10-14 | lld:pubmed |
| pubmed-article:18853322 | pubmed:abstractText | Members of the inhibitors of apoptosis proteins (IAPs) family are thought to promote tumor growth and interfere with response to therapy by suppressing apoptosis in several malignancies. We aimed to evaluate the expression of IAPs in uveal melanoma (UM) and its correlation with prognostic factors associated with death from metastatic UM. | lld:pubmed |
| pubmed-article:18853322 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18853322 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18853322 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18853322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18853322 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18853322 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:18853322 | pubmed:issn | 1460-2202 | lld:pubmed |
| pubmed-article:18853322 | pubmed:author | pubmed-author:Pe'erJacobJ | lld:pubmed |
| pubmed-article:18853322 | pubmed:author | pubmed-author:ZeschnigkMich... | lld:pubmed |
| pubmed-article:18853322 | pubmed:author | pubmed-author:ChowersItayI | lld:pubmed |
| pubmed-article:18853322 | pubmed:author | pubmed-author:MeirTalT | lld:pubmed |
| pubmed-article:18853322 | pubmed:author | pubmed-author:LedermanMicha... | lld:pubmed |
| pubmed-article:18853322 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18853322 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:18853322 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18853322 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18853322 | pubmed:pagination | 876-84 | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:meshHeading | pubmed-meshheading:18853322... | lld:pubmed |
| pubmed-article:18853322 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18853322 | pubmed:articleTitle | Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma. | lld:pubmed |
| pubmed-article:18853322 | pubmed:affiliation | Ophthalmology, Hadassah-Hebrew University Medical Center, Hebrew University School of Medicine, Jerusalem, Israel. | lld:pubmed |
| pubmed-article:18853322 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18853322 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18853322 | lld:pubmed |
